RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Earnings per share

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.3B
P/E ratio
-3.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025-14.1-22.46%
Mar 31, 2024-18.2-26.87%
Mar 31, 2023-24.9-12.78%
Mar 31, 2022-28.5-21.00%
Mar 31, 2021-36.1-18.24%
Mar 31, 2020-44.2-1.67%
Mar 31, 2019-44.9+8.97%
Mar 31, 2018-41.2+25.99%
Mar 31, 2017-32.7-7.20%
Mar 31, 2016-35.3+71.26%
Mar 31, 2015-20.6-1510.96%
Mar 31, 20141.5-91.99%
Mar 31, 201318.2+681.97%
Mar 31, 20122.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)